An experimental drug reversed paralysis and vision loss in mice with a multiple sclerosis-like disease while also preserving nerve tissue. For the nearly one million Americans living with multiple sclerosis, current treatments offer ways to slow the disease and reduce flare-ups, but they cannot restore neurological function once it is lost. The condition typically strikes […]This is a curated summary.